ArticleNeuro-oncology2025

Targeting TGFβ docking receptor glycoprotein A repetitions predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastoma.

Bill Xingjun Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.